After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

CLE may occur in association with systemic lupus erythematosus (SLE). The most common subtypes are discoid (DLE) and subacute (SCLE), accounting for 80% and 16% of cases, respectively. Both TYK2 ...

For its part, BMS is also investigating Sotyktu as a treatment for other autoimmune diseases including discoid lupus erythematosus (DLE), systemic lupus erythematosus (SLE) and Sjögren’s syndrome.

Authors of a new report on cannabinoids and atopic dermatitis—also called eczema—say their study demonstrated that an ointment including cannabidiol (CBD) and cannabigerol (CBG) was “effective in ...

Although the symptoms of discoid lupus usually only impact the skin, in rare circumstances, the disease can progress to systemic lupus erythematosus (SLE) and impact multiple organs, according to ...

Systemic lupus erythematosus (SLE) is the most common. It can affect many parts of the body. Cutaneous lupus mainly affects the skin. Discoid lupus causes a disc-shaped rash. Subacute cutaneous ...

Systemic lupus erythematosus, or lupus, is a complex autoimmune disease in which the immune system mistakenly attacks healthy tissue, often affecting the skin, joints, kidneys and nervous system.

A common form of lupus is systemic lupus erythematosus. Systemic lupus erythematosus affects the whole body and can attack virtually any part of it, including skin, major organs, hair, muscles ...